← FDA Drug Approvals (Drugs@FDA)

DOXERCALCIFEROL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-06-15

Drug application

FDA Application #

ANDA215810

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXERCALCIFEROL

Generic name

DOXERCALCIFEROL

Active ingredients

DOXERCALCIFEROL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2023-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown